Chison Medical Technologies Stock Return On Equity
| 688358 Stock | 26.51 0.24 0.91% |
Chison Medical Technologies fundamentals help investors to digest information that contributes to Chison Medical's financial success or failures. It also enables traders to predict the movement of Chison Stock. The fundamental analysis module provides a way to measure Chison Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chison Medical stock.
Chison | Return On Equity |
Chison Medical Technologies Company Return On Equity Analysis
Chison Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Chison Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Chison Medical Technologies has a Return On Equity of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The return on equity for all China stocks is 100.0% lower than that of the firm.
Chison Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chison Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chison Medical could also be used in its relative valuation, which is a method of valuing Chison Medical by comparing valuation metrics of similar companies.Chison Medical is currently under evaluation in return on equity category among its peers.
Chison Fundamentals
| Current Valuation | 1.91 B | ||||
| Price To Book | 2.16 X | ||||
| Price To Sales | 6.55 X | ||||
| Revenue | 483.84 M | ||||
| EBITDA | 125.83 M | ||||
| Net Income | 146.48 M | ||||
| Total Debt | 4.02 M | ||||
| Cash Flow From Operations | 85.91 M | ||||
| Market Capitalization | 3.55 B | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 305.98 M | ||||
| Working Capital | 1.2 B | ||||
| Net Asset | 1.52 B |
About Chison Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chison Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chison Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chison Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Chison Stock
Chison Medical financial ratios help investors to determine whether Chison Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chison with respect to the benefits of owning Chison Medical security.